Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Olujohungbe

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Postgraduate Medical Journal|March 1, 1992
Spontaneous flail chest in multiple myelomaA Olujohungbe, D Cummins
Clinical and Laboratory Haematology|January 1, 1993
Red cell distribution width (RDW) in sickle cell diseaseA Olujohungbe, B Garvey
Oral Surgery, Oral Medicine, and Oral Pathology|January 1, 1994
Mandibular nerve neuropathy in sickle cell disease. Local factorsG Gregory, A Olujohungbe
The Cochrane Database of Systematic Reviews|June 19, 2001
Hydroxyurea for sickle cell diseaseS Davies, A Olujohungbe
BMJ (Clinical Research Ed.)|March 5, 1999
Register cannot replace prospective studies in sickle cell diseaseA Yardumian, A Olujohungbe, K Cinkotai
Eye (London, England)|July 20, 2004
Bilateral acute uveitis and conjunctivitis after zoledronic acid therapyJ M Durnian, A Olujohungbe, G Kyle
Eye (London, England)|May 21, 2005
Recurrent subconjunctival and periorbital haemorrhage as the first presentation of systemic AL amyloidosis secondary to myelomaG T Higgins, A Olujohungbe, G Kyle
Postgraduate Medical Journal|March 1, 1997
Does erythropoietin accelerate malignant transformation in multiple myeloma?A Olujohungbe, S Handa, J Holmes
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 31, 1998
Renal impairment in myeloma: time for a reappraisal?N P Mallick, A Olujohungbe, M T Drayson
BMJ (Clinical Research Ed.)|June 20, 1998
Hydroxyurea therapy for sickle cell disease in Britain. Disappointing recruitment despite promising resultsA Olujohungbe, K I Cinkotai, A Yardumian
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Postgraduate Medical Journal|March 1, 1992
Spontaneous flail chest in multiple myelomaA Olujohungbe, D Cummins
Clinical and Laboratory Haematology|January 1, 1993
Red cell distribution width (RDW) in sickle cell diseaseA Olujohungbe, B Garvey
Oral Surgery, Oral Medicine, and Oral Pathology|January 1, 1994
Mandibular nerve neuropathy in sickle cell disease. Local factorsG Gregory, A Olujohungbe
The Cochrane Database of Systematic Reviews|June 19, 2001
Hydroxyurea for sickle cell diseaseS Davies, A Olujohungbe
BMJ (Clinical Research Ed.)|March 5, 1999
Register cannot replace prospective studies in sickle cell diseaseA Yardumian, A Olujohungbe, K Cinkotai
Eye (London, England)|July 20, 2004
Bilateral acute uveitis and conjunctivitis after zoledronic acid therapyJ M Durnian, A Olujohungbe, G Kyle
Eye (London, England)|May 21, 2005
Recurrent subconjunctival and periorbital haemorrhage as the first presentation of systemic AL amyloidosis secondary to myelomaG T Higgins, A Olujohungbe, G Kyle
Postgraduate Medical Journal|March 1, 1997
Does erythropoietin accelerate malignant transformation in multiple myeloma?A Olujohungbe, S Handa, J Holmes
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 31, 1998
Renal impairment in myeloma: time for a reappraisal?N P Mallick, A Olujohungbe, M T Drayson
BMJ (Clinical Research Ed.)|June 20, 1998
Hydroxyurea therapy for sickle cell disease in Britain. Disappointing recruitment despite promising resultsA Olujohungbe, K I Cinkotai, A Yardumian
Pageof 2